Viva Biotech Holdings (HKG: 1873)

Viva Biotech Holdings Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	1,036	1,036	678.57	800.95	2,308	904.09
Trading Asset Securities	-	-	-	-	49.5	29.63
Cash & Short-Term Investments	1,036	1,036	678.57	800.95	2,358	933.72
Cash Growth	-3.52%	52.72%	-15.28%	-66.03%	152.53%	500.25%
Accounts Receivable	446.72	407.41	445.97	429.7	320.51	57.51
Other Receivables	-	136.13	59.41	102.2	82.56	10.51
Receivables	446.72	543.53	505.38	531.9	403.07	68.01
Inventory	225.51	259.71	326.03	231.72	164.75	8.53
Prepaid Expenses	-	5.95	7.94	7.26	5.93	1.34
Other Current Assets	222.09	185.41	420.88	411.95	419.85	82.82
Total Current Assets	1,930	2,031	1,939	1,984	3,352	1,094
Property, Plant & Equipment	1,661	1,655	1,937	1,724	737.01	156.99
Long-Term Investments	977.41	1,038	1,047	1,247	924.53	627.08
Goodwill	2,156	2,156	2,156	2,156	1,848	-
Other Intangible Assets	393.3	420.67	476.06	531.44	469.46	-
Long-Term Accounts Receivable	6.11	5.25	6.43	16.12	15.38	5.41
Long-Term Deferred Tax Assets	21.85	21.19	18.18	7.63	9.94	3.79
Other Long-Term Assets	34.31	122.76	340.97	378.73	798.49	11.1
Total Assets	7,180	7,450	7,921	8,045	8,154	1,899
Accounts Payable	247.48	245.76	326.13	281.05	295.7	7.55
Accrued Expenses	106.37	133.35	140.37	105.85	147.68	20.74
Short-Term Debt	378.23	538.03	373.94	228.9	25	-
Current Portion of Long-Term Debt	271.84	411.48	1,540	4.15	130.55	0.53
Current Portion of Leases	3.01	2.93	2.27	5.69	11.41	24.46
Current Income Taxes Payable	14.33	32.02	41.63	41.31	15.76	11.4
Current Unearned Revenue	55.27	36.42	44.24	50.01	13.39	0.64
Other Current Liabilities	90.6	134.19	204	209.64	96.18	7.65
Total Current Liabilities	1,167	1,534	2,673	926.6	735.67	72.96
Long-Term Debt	861.2	922.01	880.96	2,388	2,799	1.34
Long-Term Leases	26.73	28.76	25.8	27.77	3.91	23.08
Long-Term Unearned Revenue	33.45	55.02	73.12	75.27	22.71	15.84
Long-Term Deferred Tax Liabilities	80.43	69.19	92.2	117.73	119.18	8.16
Other Long-Term Liabilities	1,209	1,153	571.5	595.85	717.14	-
Total Liabilities	3,378	3,762	4,316	4,131	4,397	121.39
Common Stock	0.37	0.37	0.33	0.33	0.32	0.26
Additional Paid-In Capital	-	3,874	3,637	3,637	3,651	1,299
Retained Earnings	-	-294.51	-178.4	350.08	62.53	449.41
Treasury Stock	-134.65	-134.65	-134.65	-134.65	-52.68	-
Comprensive Income & Other	3,923	242.54	280.48	60.65	95.9	29.05
Shareholders' Equity	3,802	3,688	3,605	3,913	3,757	1,777
Total Liabilities & Equity	7,180	7,450	7,921	8,045	8,154	1,899
Total Debt	1,541	1,903	2,823	2,655	2,970	49.41
Net Cash (Debt)	-505.18	-866.9	-2,144	-1,854	-611.56	884.31
Net Cash Per Share	-0.25	-0.43	-1.12	-0.94	-0.39	0.60
Filing Date Shares Outstanding	2,142	2,142	1,915	1,915	1,912	1,562
Total Common Shares Outstanding	2,142	2,142	1,915	1,915	1,912	1,562
Working Capital	763.01	496.74	-733.75	1,057	2,616	1,021
Book Value Per Share	1.77	1.72	1.88	2.04	1.97	1.14
Tangible Book Value	1,239	1,111	972.23	1,225	1,440	1,777
Tangible Book Value Per Share	0.58	0.52	0.51	0.64	0.75	1.14
Buildings	-	558.65	553.56	293.19	107.01	17.92
Machinery	-	805.36	703.13	552.49	339.45	105.73
Construction In Progress	-	338.48	469.88	542.03	132.07	11.98
Leasehold Improvements	-	26.29	26.29	37.07	33.64	18.97
Order Backlog	-	-	-	965	607	-

Source: S&P Capital IQ. Standard template. Financial Sources.